Hamilton Pharmaceuticals Overview

  • Founded
  • 2004
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $3.6M
Latest Deal Amount

Hamilton Pharmaceuticals General Information


Developer of medical treatments for diseases related to central nervous system. The company engages in the development of late-stage products for neurology and psychiatry.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare
Primary Office
  • 1825 K Street Northwest
  • Suite 520
  • Washington, DC 20006
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hamilton Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 16-Oct-2007 $3.6M 0000 00.00 Completed Startup
2. Early Stage VC (Series A) 22-Apr-2005 0000 0000 Completed Startup
1. Early Stage VC 01-Oct-2004 Completed Startup
To view Hamilton Pharmaceuticals’s complete valuation and funding history, request access »

Hamilton Pharmaceuticals Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CNF Investments PE/Buyout Minority 000 0000 000000 0
Index Ventures Venture Capital Minority 000 0000 000000 0
Vivo Capital Venture Capital Minority 000 0000 000000 0
To view Hamilton Pharmaceuticals’s complete investors history, request access »